FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382025243> ?p ?o ?g. }

• W4382025243 abstract "Abstract Methotrexate (MTX) is an effective treatment for atopic eczema (AE), but its mechanism of action remains undefined. Our previous work identified keratinocytes as a direct target of MTX by increasing epidermal differentiation. Evidence supports the concept of DNA damage-induced keratinocyte differentiation; however, this has not been characterized in the context of MTX. We tested the hypothesis that MTX may act therapeutically in AE by inducing DNA damage and activating downstream DNA damage response signalling pathways. Patients with AE starting MTX (initial dose 10 mg weekly) were recruited (n = 12). The FLG status was determined by DNA genotyping. Clinical data and skin biopsies from lesional and nonlesional skin were collected at week 0 (baseline), week 2 [visit 1 (V1)] and week 12 [visit 2 (V2)] following MTX initiation. γH2A.X, a marker of DNA damage, was quantified to explore the relationship between DNA damage secondary to MTX treatment and FLG status. γH2A.X and filaggrin protein epidermal immunostaining were quantified. The male-to-female ratio was 8 : 4 and median participant age was 45 years. Median Eczema Area and Severity Index (EASI) score improved from 23.5 (baseline, n = 12) to 14.6 at V1 (n = 12) and 9.0 at V2 (n = 8). Median Dermatology Life Quality Index reduced from 15 (baseline, n = 12) to 10.5 (V2, n = 8). Four patients were FLG heterozygotes and eight were FLG wild type. In combined analysis of all patients, epidermal γH2A.X increased in lesional skin at both time points [n = 6 (V1: P = 0.022; V2: P = 0.009)] and in nonlesional skin by V2 (n = 6; P = 0.021). γH2A.X increased in lesional skin at V2 in both FLG heterozygotes (P = 0.044) and wild types (P = 0.038). Epidermal filaggrin in lesional and nonlesional skin increased at V1 and V2 in all patients combined (n = 5; P = 0.029). Filaggrin increased in the nonlesional skin of FLG heterozygotes (P = 0.044) and in the lesional skin of FLG wild-type patients (P = 0.009) by V2. Transcriptomic (RNAseq) analysis was performed on skin biopsies (n = 11 patients; n = 42 samples). We explored the relationship of gene expression with severity (EASI) and FLG status. AKR1B10, IL22 and LGALS7 expression increased with disease severity. The AKR1B10 (regulates keratinocyte differentiation) and LGALS7 expression (expressed during barrier dysfunction) response with EASI was enhanced in FLG heterozygotes vs. wild-type patients. Canonical pathways were upregulated in lesional skin at V2 vs. baseline. Through epidermal immunostaining and transcriptomic gene analysis, we demonstrated evidence of DNA damage and filaggrin induction in patients with AE following MTX therapy, with associated improved disease outcomes." @default.
• W4382025243 created "2023-06-27" @default.
• W4382025243 creator A5008691203 @default.
• W4382025243 creator A5014775730 @default.
• W4382025243 creator A5029600332 @default.
• W4382025243 creator A5033455099 @default.
• W4382025243 creator A5034963605 @default.
• W4382025243 creator A5045379261 @default.
• W4382025243 creator A5049863628 @default.
• W4382025243 creator A5052716174 @default.
• W4382025243 date "2023-06-01" @default.
• W4382025243 modified "2023-10-07" @default.
• W4382025243 title "P39 Methotrexate induces epidermal DNA damage response and filaggrin in atopic eczema" @default.
• W4382025243 doi "https://doi.org/10.1093/bjd/ljad113.067" @default.
• W4382025243 hasPublicationYear "2023" @default.
• W4382025243 type Work @default.
• W4382025243 citedByCount "0" @default.
• W4382025243 crossrefType "journal-article" @default.
• W4382025243 hasAuthorship W4382025243A5008691203 @default.
• W4382025243 hasAuthorship W4382025243A5014775730 @default.
• W4382025243 hasAuthorship W4382025243A5029600332 @default.
• W4382025243 hasAuthorship W4382025243A5033455099 @default.
• W4382025243 hasAuthorship W4382025243A5034963605 @default.
• W4382025243 hasAuthorship W4382025243A5045379261 @default.
• W4382025243 hasAuthorship W4382025243A5049863628 @default.
• W4382025243 hasAuthorship W4382025243A5052716174 @default.
• W4382025243 hasBestOaLocation W43820252431 @default.
• W4382025243 hasConcept C126322002 @default.
• W4382025243 hasConcept C143425029 @default.
• W4382025243 hasConcept C151730666 @default.
• W4382025243 hasConcept C16005928 @default.
• W4382025243 hasConcept C190684412 @default.
• W4382025243 hasConcept C203014093 @default.
• W4382025243 hasConcept C204232928 @default.
• W4382025243 hasConcept C2778329239 @default.
• W4382025243 hasConcept C2779343474 @default.
• W4382025243 hasConcept C2781059491 @default.
• W4382025243 hasConcept C4224716 @default.
• W4382025243 hasConcept C54355233 @default.
• W4382025243 hasConcept C552990157 @default.
• W4382025243 hasConcept C71924100 @default.
• W4382025243 hasConcept C86803240 @default.
• W4382025243 hasConceptScore W4382025243C126322002 @default.
• W4382025243 hasConceptScore W4382025243C143425029 @default.
• W4382025243 hasConceptScore W4382025243C151730666 @default.
• W4382025243 hasConceptScore W4382025243C16005928 @default.
• W4382025243 hasConceptScore W4382025243C190684412 @default.
• W4382025243 hasConceptScore W4382025243C203014093 @default.
• W4382025243 hasConceptScore W4382025243C204232928 @default.
• W4382025243 hasConceptScore W4382025243C2778329239 @default.
• W4382025243 hasConceptScore W4382025243C2779343474 @default.
• W4382025243 hasConceptScore W4382025243C2781059491 @default.
• W4382025243 hasConceptScore W4382025243C4224716 @default.
• W4382025243 hasConceptScore W4382025243C54355233 @default.
• W4382025243 hasConceptScore W4382025243C552990157 @default.
• W4382025243 hasConceptScore W4382025243C71924100 @default.
• W4382025243 hasConceptScore W4382025243C86803240 @default.
• W4382025243 hasIssue "Supplement_4" @default.
• W4382025243 hasLocation W43820252431 @default.
• W4382025243 hasOpenAccess W4382025243 @default.
• W4382025243 hasPrimaryLocation W43820252431 @default.
• W4382025243 hasRelatedWork W2018193142 @default.
• W4382025243 hasRelatedWork W2069430598 @default.
• W4382025243 hasRelatedWork W2312332875 @default.
• W4382025243 hasRelatedWork W2317277868 @default.
• W4382025243 hasRelatedWork W2334095267 @default.
• W4382025243 hasRelatedWork W2555413088 @default.
• W4382025243 hasRelatedWork W4297184974 @default.
• W4382025243 hasRelatedWork W4308132322 @default.
• W4382025243 hasRelatedWork W4316674137 @default.
• W4382025243 hasRelatedWork W825671244 @default.
• W4382025243 hasVolume "188" @default.
• W4382025243 isParatext "false" @default.
• W4382025243 isRetracted "false" @default.
• W4382025243 workType "article" @default.